<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7090771\results\search\disease\results.xml">
  <result pre="Review Article Diagnosis, treatment, and prevention of 2019 novel coronavirus" exact="infection" post="in children: expertsâ€™ consensus statement ShenKunlingkunlingshen1717@163.com1YangYonghongyyh628628@sina.com2WangTianyou3ZhaoDongchizhao_wh2004@hotmail.com4JiangYi5JinRunming6ZhengYuejie7XuBaoping1XieZhengde2LinLikai8ShangYunxiao9LuXiaoxia10ShuSainan11BaiYan6DengJikui12LuMin13YeLeping14WangXuefeng15WangYongyan16GaoLiwei1collab: China National Clinical"/>
  <result pre="expertsâ€™ consensus statement ShenKunlingkunlingshen1717@163.com1YangYonghongyyh628628@sina.com2WangTianyou3ZhaoDongchizhao_wh2004@hotmail.com4JiangYi5JinRunming6ZhengYuejie7XuBaoping1XieZhengde2LinLikai8ShangYunxiao9LuXiaoxia10ShuSainan11BaiYan6DengJikui12LuMin13YeLeping14WangXuefeng15WangYongyan16GaoLiwei1collab: China National Clinical Research Center for" exact="Respiratory" post="Diseasescollab: National Center for Childrenâ€™s Health, Beijing, Chinacollab: Group"/>
  <result pre="Center for Childrenâ€™s Health, Beijing, Chinacollab: Group of Respirology, Chinese" exact="Pediatric" post="Society, Chinese Medical Associationcollab: Chinese Medical Doctor Association Committee"/>
  <result pre="of Drug Information Association, Committee on Childrenâ€™s Safety Medicationcollab: Global" exact="Pediatric" post="Pulmonology Alliance[1], grid.24696.3f0000 0004 0369 153XDepartment of Respiratory Medicine,"/>
  <result pre="Medicationcollab: Global Pediatric Pulmonology Alliance[1], grid.24696.3f0000 0004 0369 153XDepartment of" exact="Respiratory" post="Medicine, Beijing Childrenâ€™s Hospital, Capital Medical University, [2], grid.24696.3f0000"/>
  <result pre="Childrenâ€™s Hospital, Capital Medical University, [2], grid.24696.3f0000 0004 0369 153XBeijing" exact="Pediatric" post="Research Institute, Beijing Childrenâ€™s Hospital, Capital Medical University, [3],"/>
  <result pre="of Science and Technology, [7], grid.452787.b0000 0004 1806 5224Department of" exact="Respiratory" post="Medicine, Shenzhen Childrenâ€™s Hospital, [8], grid.413247.7Hospital Management Institute of"/>
  <result pre="Hospital of Wuhan University, [9], grid.412467.20000 0004 1806 3501Department of" exact="Pediatric" post="Respiratory, Shengjing Hospital of China Medical University, [10], grid.33199.310000"/>
  <result pre="of China Medical University, [10], grid.33199.310000 0004 0368 7223Department of" exact="Respiratory" post="Medicine, Wuhan Childrenâ€™s Hospital, Tongji Medical College, Huazhong University"/>
  <result pre="of Science and Technology, [12], grid.452787.b0000 0004 1806 5224Department of" exact="Infectious" post="Disease, Shenzhen Childrenâ€™s Hospital, [13], [14], grid.411472.50000 0004 1764"/>
  <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
  <result pre="global pandemic. Abstract Since the outbreak of 2019 novel coronavirus" exact="infection" post="(2019-nCoV) in Wuhan City, China, by January 30, 2020,"/>
  <result pre="(2019-nCoV) in Wuhan City, China, by January 30, 2020, a" exact="total" post="of 9692 confirmed cases and 15,238 suspected cases have"/>
  <result pre="at home, and 213 died. And among these cases, aÂ" exact="total" post="of 28 children aged from 1Â month to 17Â"/>
  <result pre="reported in China. For standardizing prevention and management of 2019-nCoV" exact="infections" post="in children, we called up an expertsâ€™ committee to"/>
  <result pre="consensus statement. This statement is based on the Novel Coronavirus" exact="Infection" post="Pneumonia Diagnosis and Treatment Standards (the fourth edition) (National"/>
  <result pre="statement. This statement is based on the Novel Coronavirus Infection" exact="Pneumonia" post="Diagnosis and Treatment Standards (the fourth edition) (National Health"/>
  <result pre="summarizes current strategies on diagnosis, treatment, and prevention of 2019-nCoV" exact="infection" post="in children. Background In December, 2019, a cluster of"/>
  <result pre="infection in children. Background In December, 2019, a cluster of" exact="pneumonia" post="cases, who were later proven to be caused by"/>
  <result pre="(229E and NL63), Î²-coronaviruses (OC43 and HKU1), the Middle East" exact="respiratory" post="syndrome-related coronavirus (MERS-CoV), severe acute respiratory syndrome-related coronavirus (SARS-CoV),"/>
  <result pre="and HKU1), the Middle East respiratory syndrome-related coronavirus (MERS-CoV), severe" exact="acute" post="respiratory syndrome-related coronavirus (SARS-CoV), and 2019-nCoV. The 2019-nCoV belongs"/>
  <result pre="HKU1), the Middle East respiratory syndrome-related coronavirus (MERS-CoV), severe acute" exact="respiratory" post="syndrome-related coronavirus (SARS-CoV), and 2019-nCoV. The 2019-nCoV belongs to"/>
  <result pre="exact origin remains unclear. 2019-nCoV infected patients are the main" exact="infection" post="sources. However, we also should attach importance to asymptomatic"/>
  <result pre="which may play a critical role in the transmission process." exact="Respiratory" post="droplets and contact are the main transmission routes [3]."/>
  <result pre="contact are the main transmission routes [3]. Close contact with" exact="symptomatic" post="cases and asymptomatic cases with silent infection are the"/>
  <result pre="Close contact with symptomatic cases and asymptomatic cases with silent" exact="infection" post="are the main transmission routes of 2019-nCoV infection in"/>
  <result pre="with silent infection are the main transmission routes of 2019-nCoV" exact="infection" post="in children. People of all ages are susceptible to"/>
  <result pre="are susceptible to 2019-nCoV. The elderly and those with underlying" exact="chronic" post="diseases are more likely to become severe cases. Thus"/>
  <result pre="severe cases. Thus far, all pediatric cases with laboratory-confirmed 2019-nCoV" exact="infection" post="were mild cases, andÂ no deaths hadÂ been reported."/>
  <result pre="been reported. For standardizing the prevention and treament of 2019-nCoV" exact="infections" post="in children, we called up an expertsâ€™ committee to"/>
  <result pre="consensus statement. This statement is based on the Novel Coronavirus" exact="Infection" post="Pneumonia Diagnosis and Treatment Standards (the fourth edition) (National"/>
  <result pre="statement. This statement is based on the Novel Coronavirus Infection" exact="Pneumonia" post="Diagnosis and Treatment Standards (the fourth edition) (National Health"/>
  <result pre="on the current epidemiological data, the incubation period of 2019-nCoV" exact="infections" post="ranges from 1 to 14Â days, mostly ranging from"/>
  <result pre="reported data of pediatric cases revealed that the age of" exact="disease" post="onset ranged from 1.5Â months to 17Â years, most"/>
  <result pre="present with fever, dry cough, and fatigue, and few have" exact="upper" post="respiratory symptoms including nasal congestion and running nose; some"/>
  <result pre="with fever, dry cough, and fatigue, and few have upper" exact="respiratory" post="symptoms including nasal congestion and running nose; some patients"/>
  <result pre="mild clinical manifestations. They have no fever or symptoms of" exact="pneumonia" post="with a good prognosis. Most of them recover within"/>
  <result pre="good prognosis. Most of them recover within 1â€&quot;2Â weeks after" exact="disease" post="onset. Few may progress to lower respiratory infections. No"/>
  <result pre="within 1â€&quot;2Â weeks after disease onset. Few may progress to" exact="lower" post="respiratory infections. No newborns delivered by 2019-nCoV infected mothers"/>
  <result pre="1â€&quot;2Â weeks after disease onset. Few may progress to lower" exact="respiratory" post="infections. No newborns delivered by 2019-nCoV infected mothers have"/>
  <result pre="reveal that severe cases often develop dyspnea one week after" exact="disease" post="onset. Severe cases may rapidly progress to acute respiratory"/>
  <result pre="severe cases often develop dyspnea one week after disease onset." exact="Severe" post="cases may rapidly progress to acute respiratory distress syndrome"/>
  <result pre="week after disease onset. Severe cases may rapidly progress to" exact="acute" post="respiratory distress syndrome (ARDS), septic shock, refractory metabolic acidosis,"/>
  <result pre="after disease onset. Severe cases may rapidly progress to acute" exact="respiratory" post="distress syndrome (ARDS), septic shock, refractory metabolic acidosis, and"/>
  <result pre="onset. Severe cases may rapidly progress to acute respiratory distress" exact="syndrome" post="(ARDS), septic shock, refractory metabolic acidosis, and coagulation dysfunction"/>
  <result pre="cases may rapidly progress to acute respiratory distress syndrome (ARDS)," exact="septic shock," post="refractory metabolic acidosis, and coagulation dysfunction [6, 7]. Although"/>
  <result pre="progress to acute respiratory distress syndrome (ARDS), septic shock, refractory" exact="metabolic acidosis," post="and coagulation dysfunction [6, 7]. Although no deaths in"/>
  <result pre="in pediatric patients are relatively milder compared with those in" exact="adult" post="patients, ARDS and death cases also occurred in infected"/>
  <result pre="is normal or decreased, with decreased lymphocyte count; liver enzymes," exact="muscle" post="enzymes, and myohemoglobin levels are increased in some patients."/>
  <result pre="protein level and erythrocyte sedimentation rates, and normal procalcitonin levels." exact="Severe" post="cases show high D-dimer levels and progressively decreased blood"/>
  <result pre="from throat swabs (better using nasopharyngeal swab in children), sputum," exact="lower" post="respiratory tract secretions, stool and blood, etc. are tested"/>
  <result pre="throat swabs (better using nasopharyngeal swab in children), sputum, lower" exact="respiratory" post="tract secretions, stool and blood, etc. are tested positive"/>
  <result pre="imaging examination [3] Suspected cases or confirmed cases should undertake" exact="chest" post="X-ray examination as soon as possible. Chest CT scan"/>
  <result pre="is required when necessary. In the early stage of disease," exact="chest" post="images show multiple small plaques and interstitial changes, which"/>
  <result pre="which are obvious in the lung periphery, further deteriorate to" exact="bilateral" post="multiple ground-glass opacity and/or infiltrating shadows. Lung consolidation may"/>
  <result pre="lung periphery, further deteriorate to bilateral multiple ground-glass opacity and/or" exact="infiltrating" post="shadows. Lung consolidation may occur in severe cases. Pleural"/>
  <result pre="and/or infiltrating shadows. Lung consolidation may occur in severe cases." exact="Pleural" post="effusion is rarely seen. Diagnosis Suspected cases 2019-nCoV should"/>
  <result pre="areas with persistent local transmission within 14Â days prior to" exact="disease" post="onset; Children with a history of contacting patients with"/>
  <result pre="Children with a history of contacting patients with fever or" exact="respiratory" post="symptoms who have a history of contact with patients"/>
  <result pre="areas with persistent local transmission within 14Â days prior to" exact="disease" post="onset; Children who are related with a cluster outbreak"/>
  <result pre="patients may have low-grade fever or no fever; With above-mentioned" exact="chest" post="imaging findings (refer to the section of Chest imaging"/>
  <result pre="cases who meet any one of the following criteria [3]:" exact="Respiratory" post="tract or blood samples tested positive for 2019-nCoV nucleic"/>
  <result pre="positive for 2019-nCoV nucleic acid using RT-PCR; Genetic sequencing of" exact="respiratory" post="tract or blood samples is highly homologous with the"/>
  <result pre="is highly homologous with the known 2019-nCoV. Clinical classifications Asymptomatic" exact="infection" post="(silent infection) Children tested positive for 2019-nCoV, but without"/>
  <result pre="for 2019-nCoV, but without manifestations of clinical symptoms or abnormal" exact="chest" post="imaging findings. Acute upper respiratory tract infection Children with"/>
  <result pre="without manifestations of clinical symptoms or abnormal chest imaging findings." exact="Acute" post="upper respiratory tract infection Children with only fever, cough,"/>
  <result pre="manifestations of clinical symptoms or abnormal chest imaging findings. Acute" exact="upper respiratory tract infection" post="Children with only fever, cough, pharyngeal pain, nasal congestion,"/>
  <result pre="of clinical symptoms or abnormal chest imaging findings. Acute upper" exact="respiratory" post="tract infection Children with only fever, cough, pharyngeal pain,"/>
  <result pre="symptoms or abnormal chest imaging findings. Acute upper respiratory tract" exact="infection" post="Children with only fever, cough, pharyngeal pain, nasal congestion,"/>
  <result pre="fatigue, headache, myalgia or discomfort, etc., and without signs of" exact="pneumonia" post="by chest imaging or sepsis. Mild pneumonia Children with"/>
  <result pre="myalgia or discomfort, etc., and without signs of pneumonia by" exact="chest" post="imaging or sepsis. Mild pneumonia Children with or without"/>
  <result pre="without signs of pneumonia by chest imaging or sepsis. Mild" exact="pneumonia" post="Children with or without fever, respiratory symptoms such as"/>
  <result pre="imaging or sepsis. Mild pneumonia Children with or without fever," exact="respiratory" post="symptoms such as cough; and chest imaging indicating pneumonia,"/>
  <result pre="with or without fever, respiratory symptoms such as cough; and" exact="chest" post="imaging indicating pneumonia, but not reaching the criteria of"/>
  <result pre="indicating pneumonia, but not reaching the criteria of severe pneumonia." exact="Severe" post="pneumonia Meeting any of the following criteria [3, 12â€&quot;15]:"/>
  <result pre="pneumonia, but not reaching the criteria of severe pneumonia. Severe" exact="pneumonia" post="Meeting any of the following criteria [3, 12â€&quot;15]: Increased"/>
  <result pre="Severe pneumonia Meeting any of the following criteria [3, 12â€&quot;15]:" exact="Increased" post="respiratory rate:â€‰â‰¥â€‰70 times/min ( Oxygen saturationâ€‰ Hypoxia: assisted breathing"/>
  <result pre="pneumonia Meeting any of the following criteria [3, 12â€&quot;15]: Increased" exact="respiratory" post="rate:â€‰â‰¥â€‰70 times/min ( Oxygen saturationâ€‰ Hypoxia: assisted breathing (moans,"/>
  <result pre="meet any of the following criteria and require ICU care:" exact="Respiratory" post="failure requiring mechanical ventilation; Shock; Combined with other organs"/>
  <result pre="and require ICU care: Respiratory failure requiring mechanical ventilation; Shock;" exact="Combined" post="with other organs failure. Early identification of critical cases"/>
  <result pre="According to the experiences in diagnosis and treatment of community-acquired" exact="pneumonia" post="in children, children with a history of contact with"/>
  <result pre="severe 2019-nCoV infected cases, or with underlying conditions (such as" exact="congenital" post="heart disease, bronchial pulmonary hypoplasia, respiratory tract anomaly, with"/>
  <result pre="2019-nCoV infected cases, or with underlying conditions (such as congenital" exact="heart" post="disease, bronchial pulmonary hypoplasia, respiratory tract anomaly, with abnormal"/>
  <result pre="or with underlying conditions (such as congenital heart disease, bronchial" exact="pulmonary" post="hypoplasia, respiratory tract anomaly, with abnormal hemoglobin level, severe"/>
  <result pre="underlying conditions (such as congenital heart disease, bronchial pulmonary hypoplasia," exact="respiratory" post="tract anomaly, with abnormal hemoglobin level, severe malnutrition), or"/>
  <result pre="anomaly, with abnormal hemoglobin level, severe malnutrition), or with immune" exact="deficiency" post="or immunocompromised status (under long-term use of immunosuppressants) who"/>
  <result pre="one of the following criteria may become severe cases: Dyspnea:" exact="respiratory" post="rateÂ &amp;gt;â€‰50 times/min for 2â€&quot;12Â months old;â€‰&amp;gt;â€‰40 times/min for"/>
  <result pre="indexes, such as myocardial enzymes, liver enzymes, lactate dehydrogenase; Unexplainable" exact="metabolic acidosis;" post="Chest imaging findings indicating bilateral or multi-lobe infiltration, pleural"/>
  <result pre="enzymes, lactate dehydrogenase; Unexplainable metabolic acidosis; Chest imaging findings indicating" exact="bilateral" post="or multi-lobe infiltration, pleural effusion, or rapid progression of"/>
  <result pre="metabolic acidosis; Chest imaging findings indicating bilateral or multi-lobe infiltration," exact="pleural" post="effusion, or rapid progression of conditions during a very"/>
  <result pre="pleural effusion, or rapid progression of conditions during a very" exact="short" post="period; Infants younger than 3Â months; Extrapulmonary complications; Coinfection"/>
  <result pre="be made to distinguish from influenza virus, parainfluenza virus, adenovirus," exact="respiratory" post="syncytial virus, rhinovirus, human metapneumovirus, SARS coronavirus, and other"/>
  <result pre="syncytial virus, rhinovirus, human metapneumovirus, SARS coronavirus, and other known" exact="viral" post="infections, as well as mycoplasma pneumoniae and chlamydia pneumonia"/>
  <result pre="other known viral infections, as well as mycoplasma pneumoniae and" exact="chlamydia" post="pneumonia and bacterial pneumonia. The coinfection of 2019-nCoV with"/>
  <result pre="known viral infections, as well as mycoplasma pneumoniae and chlamydia" exact="pneumonia" post="and bacterial pneumonia. The coinfection of 2019-nCoV with other"/>
  <result pre="infections, as well as mycoplasma pneumoniae and chlamydia pneumonia and" exact="bacterial pneumonia." post="The coinfection of 2019-nCoV with other viruses and/or bacteria"/>
  <result pre="cases should be admitted to ICU as soon as possible." exact="General" post="treatment The general treatment strategies include bed rest and"/>
  <result pre="balance and homeostasis; monitoring vital signs and oxygen saturation; keeping" exact="respiratory" post="tract unobstructed and inhaling oxygen when necessary; measuring blood"/>
  <result pre="myocardial enzyme spectrum, and coagulation function according to patientsâ€™ conditions." exact="Blood" post="gas analysis and timely re-examination of chest imaging should"/>
  <result pre="to patientsâ€™ conditions. Blood gas analysis and timely re-examination of" exact="chest" post="imaging should be performed when necessary. Symptomatic treatment The"/>
  <result pre="Keep children quiet and administrate sedatives immediately when convulsions or" exact="seizure" post="occur. Oxygen therapy When hypoxia appears, effective oxygen therapy"/>
  <result pre="sedatives immediately when convulsions or seizure occur. Oxygen therapy When" exact="hypoxia" post="appears, effective oxygen therapy should be given immediately including"/>
  <result pre="when necessary. Antiviral therapy Interferon-Î± [3, 16â€&quot;28] Interferon-Î± can reduce" exact="viral" post="load in the early stage of infection which can"/>
  <result pre="Interferon-Î± can reduce viral load in the early stage of" exact="infection" post="which can help to alleviate symptoms and shorten the"/>
  <result pre="clinical research and experiences of using interferon-Î± in treating bronchiolitis," exact="viral pneumonia," post="acute upper respiratory tract infection, hand foot mouth disease,"/>
  <result pre="and experiences of using interferon-Î± in treating bronchiolitis, viral pneumonia," exact="acute" post="upper respiratory tract infection, hand foot mouth disease, SARS,"/>
  <result pre="experiences of using interferon-Î± in treating bronchiolitis, viral pneumonia, acute" exact="upper respiratory tract infection," post="hand foot mouth disease, SARS, and other viral infections"/>
  <result pre="of using interferon-Î± in treating bronchiolitis, viral pneumonia, acute upper" exact="respiratory" post="tract infection, hand foot mouth disease, SARS, and other"/>
  <result pre="respiratory tract infection, hand foot mouth disease, SARS, and other" exact="viral" post="infections in children, the recommended usage is as follows:"/>
  <result pre="tract infection, hand foot mouth disease, SARS, and other viral" exact="infections" post="in children, the recommended usage is as follows: Interferon-Î±"/>
  <result pre="infected patients or those in the early phase with only" exact="upper" post="respiratory tract symptoms. Patients should use 1â€&quot;2 sprays on"/>
  <result pre="patients or those in the early phase with only upper" exact="respiratory" post="tract symptoms. Patients should use 1â€&quot;2 sprays on each"/>
  <result pre="Lopinavir/litonavir has been tried to apply to the treatment of" exact="adult" post="patients with 2019-nCoV pneumonia, but its efficacy and safety"/>
  <result pre="to the changes of conditions in children with coinfection of" exact="bacterial" post="or fungal infection; actively collecting samples for pathogen analysis"/>
  <result pre="changes of conditions in children with coinfection of bacterial or" exact="fungal infection;" post="actively collecting samples for pathogen analysis and timely or"/>
  <result pre="use of glucocorticoids should be based on the severity of" exact="systemic" post="inflammatory response, degree of dyspnea, with or without ARDS,"/>
  <result pre="dyspnea, with or without ARDS, and the progress status of" exact="chest" post="imaging results. Glucocorticoids can be used in a short"/>
  <result pre="of chest imaging results. Glucocorticoids can be used in a" exact="short" post="period (3â€&quot;5Â days). The recommended dose of methylprednisolone should"/>
  <result pre="and critically ill cases [3, 12] On the basis of" exact="symptomatic" post="treatment, we should actively prevent and treat complications, underlying"/>
  <result pre="treatment, we should actively prevent and treat complications, underlying diseases," exact="secondary" post="infection, and provide organ function support as indicated. Respiratory"/>
  <result pre="diseases, secondary infection, and provide organ function support as indicated." exact="Respiratory" post="support Children who undergo non-invasive mechanical ventilation for 2Â"/>
  <result pre="drugs, and monitor hemodynamics if necessary. Traditional Chinese medicine This" exact="disease" post="belongs to the epidemic disease category of Traditional Chinese"/>
  <result pre="necessary. Traditional Chinese medicine This disease belongs to the epidemic" exact="disease" post="category of Traditional Chinese Medicine and results from contracting"/>
  <result pre="Fuling, 3â€&quot;6Â g ofÂ Shengjiang, and 3â€&quot;6Â g ofÂ Gancao." exact="Plague" post="poison obstructing lungs: Clinical manifestation: fever persists or chill"/>
  <result pre="(Cinnamomum cassia), to be taken with Angong Niuhuang Pill. Qi" exact="deficiency" post="of both the lung and spleen. Clinical manifestation: feeble"/>
  <result pre="ofÂ Sharen (Fructus amomi) (to be added in later). Psychotherapy" exact="Psychological" post="counseling plays an important role in disease recovery. If"/>
  <result pre="in later). Psychotherapy Psychological counseling plays an important role in" exact="disease" post="recovery. If patients (especially older children) show mood swing,"/>
  <result pre="body temperature returns to normal longer than 3Â days; The" exact="respiratory" post="symptoms improve obviously; The detection of respiratory pathogenic nucleic"/>
  <result pre="3Â days; The respiratory symptoms improve obviously; The detection of" exact="respiratory" post="pathogenic nucleic acid is negative for two consecutive times"/>
  <result pre="patients can be discharged from isolation when the detection of" exact="respiratory" post="pathogenic nucleic acid is negative for two consecutive times"/>
  <result pre="interval is at least 1Â day). Prevention [33â€&quot;35] Novel coronavirus" exact="infection" post="is a new communicable disease with an emergent outbreak"/>
  <result pre="1Â day). Prevention [33â€&quot;35] Novel coronavirus infection is a new" exact="communicable disease" post="with an emergent outbreak that affects all populations. 2019-nCoV"/>
  <result pre="day). Prevention [33â€&quot;35] Novel coronavirus infection is a new communicable" exact="disease" post="with an emergent outbreak that affects all populations. 2019-nCoV"/>
  <result pre="disease with an emergent outbreak that affects all populations. 2019-nCoV" exact="infection" post="has been classified as category B infectious disease legally"/>
  <result pre="all populations. 2019-nCoV infection has been classified as category B" exact="infectious disease" post="legally but managed as category A infectious disease. It"/>
  <result pre="populations. 2019-nCoV infection has been classified as category B infectious" exact="disease" post="legally but managed as category A infectious disease. It"/>
  <result pre="category B infectious disease legally but managed as category A" exact="infectious disease." post="It is paramount to implement infection control practices by"/>
  <result pre="as category A infectious disease. It is paramount to implement" exact="infection" post="control practices by infection source controlling, transmission route blocking,"/>
  <result pre="disease. It is paramount to implement infection control practices by" exact="infection" post="source controlling, transmission route blocking, and susceptible population protection."/>
  <result pre="source controlling, transmission route blocking, and susceptible population protection. Controlling" exact="infection" post="sources Patients infected with 2019-nCoV are the main infection"/>
  <result pre="Controlling infection sources Patients infected with 2019-nCoV are the main" exact="infection" post="sources. Children infected by novel coronavirus should be isolated"/>
  <result pre="care of the sick. Blocking transmission routes Preventing transmission by" exact="respiratory" post="droplets and contact: Cover mouth and nose with napkin"/>
  <result pre="designated hospital for screening. Newborns delivered by infected mothers must" exact="complete" post="a pathogen test and be isolated in a single"/>
  <result pre="the powerful measures to preventing infection, as well as maintaining" exact="emotional" post="stability and mental health. Vaccination is an effective way"/>
  <result pre="and mental health. Vaccination is an effective way to prevent" exact="virus infection." post="The research and development of anti-virus vaccines has been"/>
  <result pre="20 Jan 2020. 2.ZhuNZhangDWangWLiXYangBSongJet al.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med.202010.1056/NEJMoa200101731978945 3.National Health Commission"/>
  <result pre="Commission of Peopleâ€™s Republic of China. Diagnosis and treatment of" exact="pneumonia" post="caused by novel coronavirus (trial version 4). https://www.nhc.gov.cn/xcs/zhengcwj/202001/4294563ed35b43209b31739bd0785e67/files/7a9309111267475a99d4306962c8bf78.pdf. Access"/>
  <result pre="Associationcollab: The Society of Pediatrics of Wuhan Medical Associationcollab: Hubei" exact="Pediatric" post="Medical Quality Control CenterSuggestions on the diagnosis and treatment"/>
  <result pre="Control CenterSuggestions on the diagnosis and treatment of novel coronavirus" exact="infection" post="in children in Hubei province (trial version 1)CJCP.202022969932051073 5.ChanJFYuanSKokKHWangKKChuHYangJet"/>
  <result pre="in children in Hubei province (trial version 1)CJCP.202022969932051073 5.ChanJFYuanSKokKHWangKKChuHYangJet al.A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
  <result pre="Hubei province (trial version 1)CJCP.202022969932051073 5.ChanJFYuanSKokKHWangKKChuHYangJet al.A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person to-person"/>
  <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet202010.1016/S0140-6736(20)30211-732007192 8.LiZZShenKLWeiXMWangHLLuJTianHet al.Clinical analysis"/>
  <result pre="pediatric SARS cases in BeijingChin J Pediatr200341574577 9.YangYHConcern for severe" exact="acute" post="respiratory syndromChin J Pediatr200341401402 10.ZengQYLiuLZengHSYuMHYeQCDengLet al.Clinical characteristics and prognosis"/>
  <result pre="SARS cases in BeijingChin J Pediatr200341574577 9.YangYHConcern for severe acute" exact="respiratory" post="syndromChin J Pediatr200341401402 10.ZengQYLiuLZengHSYuMHYeQCDengLet al.Clinical characteristics and prognosis of"/>
  <result pre="10.ZengQYLiuLZengHSYuMHYeQCDengLet al.Clinical characteristics and prognosis of 33 children with severe" exact="acute" post="respiratory syndrome in Guangzhou areaChin J Pediatr200341408 11.ThabetFChehabMBafaqihHAlMSMiddle East"/>
  <result pre="al.Clinical characteristics and prognosis of 33 children with severe acute" exact="respiratory" post="syndrome in Guangzhou areaChin J Pediatr200341408 11.ThabetFChehabMBafaqihHAlMSMiddle East respiratory"/>
  <result pre="characteristics and prognosis of 33 children with severe acute respiratory" exact="syndrome" post="in Guangzhou areaChin J Pediatr200341408 11.ThabetFChehabMBafaqihHAlMSMiddle East respiratory syndrome"/>
  <result pre="acute respiratory syndrome in Guangzhou areaChin J Pediatr200341408 11.ThabetFChehabMBafaqihHAlMSMiddle East" exact="respiratory" post="syndrome coronavirus in childrenSaudi Med J20153648448610.15537/smj.2015.4.1024325828287 12.National Health Commission"/>
  <result pre="respiratory syndrome in Guangzhou areaChin J Pediatr200341408 11.ThabetFChehabMBafaqihHAlMSMiddle East respiratory" exact="syndrome" post="coronavirus in childrenSaudi Med J20153648448610.15537/smj.2015.4.1024325828287 12.National Health Commission of"/>
  <result pre="of China. Code for the diagnosis and treatment of community-acquired" exact="pneumonia" post="in children (2019 edition). https://www.nhc.gov.cn/yzygj/s7653/201902/bfa758ad6add48a599bc74b588a6e89a.shtml. Access 11 Feb 2019."/>
  <result pre="https://www.nhc.gov.cn/yzygj/s7653/201902/bfa758ad6add48a599bc74b588a6e89a.shtml. Access 11 Feb 2019. 13.collab: The Subspecialty Group of" exact="Respiratory" post="Diseases of The Society of Pediatrics of Chinese Medical"/>
  <result pre="Access 11 Feb 2019. 13.collab: The Subspecialty Group of Respiratory" exact="Diseases" post="of The Society of Pediatrics of Chinese Medical AssociationGuidelines"/>
  <result pre="of Pediatrics of Chinese Medical AssociationGuidelines for management of community" exact="acquired" post="pneumonia in childrenChin J Pediatr.201351145152 14.HarrisMClarkJCooteNFletcherPHarndenAMcKeanMet al.British Thoracic Society"/>
  <result pre="Pediatrics of Chinese Medical AssociationGuidelines for management of community acquired" exact="pneumonia" post="in childrenChin J Pediatr.201351145152 14.HarrisMClarkJCooteNFletcherPHarndenAMcKeanMet al.British Thoracic Society guidelines"/>
  <result pre="of community acquired pneumonia in childrenChin J Pediatr.201351145152 14.HarrisMClarkJCooteNFletcherPHarndenAMcKeanMet al.British" exact="Thoracic" post="Society guidelines for the management of community acquired pneumonia"/>
  <result pre="14.HarrisMClarkJCooteNFletcherPHarndenAMcKeanMet al.British Thoracic Society guidelines for the management of community" exact="acquired" post="pneumonia in children: update 2011Thorax20116612310.1136/thoraxjnl-2011-20059820978027 15.BradleyJSByingtonCLShahSSAlversonBCarterERHarrisonCet al.The management of"/>
  <result pre="al.British Thoracic Society guidelines for the management of community acquired" exact="pneumonia" post="in children: update 2011Thorax20116612310.1136/thoraxjnl-2011-20059820978027 15.BradleyJSByingtonCLShahSSAlversonBCarterERHarrisonCet al.The management of community-acquired"/>
  <result pre="pneumonia in children: update 2011Thorax20116612310.1136/thoraxjnl-2011-20059820978027 15.BradleyJSByingtonCLShahSSAlversonBCarterERHarrisonCet al.The management of community-acquired" exact="pneumonia" post="in infants and children older than 3 months of"/>
  <result pre="than 3 months of age: clinical practice guidelines by the" exact="Pediatric" post="Infectious Diseases Society and the Infectious Diseases Society of"/>
  <result pre="3 months of age: clinical practice guidelines by the Pediatric" exact="Infectious" post="Diseases Society and the Infectious Diseases Society of AmericaClin"/>
  <result pre="months of age: clinical practice guidelines by the Pediatric Infectious" exact="Diseases" post="Society and the Infectious Diseases Society of AmericaClin Infect"/>
  <result pre="practice guidelines by the Pediatric Infectious Diseases Society and the" exact="Infectious" post="Diseases Society of AmericaClin Infect Dis201153e257610.1093/cid/cir53121880587 16.WangBXFishENGlobal virus outbreaks:"/>
  <result pre="guidelines by the Pediatric Infectious Diseases Society and the Infectious" exact="Diseases" post="Society of AmericaClin Infect Dis201153e257610.1093/cid/cir53121880587 16.WangBXFishENGlobal virus outbreaks: interferons"/>
  <result pre="and interferon therapy in patients infected with the Middle East" exact="respiratory" post="syndrome coronavirus: an observational studyInt J Infect Dis201420424610.1016/j.ijid.2013.12.00324406736 18.WangHQMaLLJiangJDPangRChenYJLiYHRecombinant"/>
  <result pre="interferon therapy in patients infected with the Middle East respiratory" exact="syndrome" post="coronavirus: an observational studyInt J Infect Dis201420424610.1016/j.ijid.2013.12.00324406736 18.WangHQMaLLJiangJDPangRChenYJLiYHRecombinant human"/>
  <result pre="vitroActa Pharmaceu Sin20144915471553 19.HijanoDRSiefkerDTShresthaBJaligamaSType I interferon potentiates IgA immunity to" exact="respiratory" post="syncytial virus infection during infancySci Rep201881103410.1038/s41598-018-29456-w30038294 20.ShenKLShangYXZhangGCXuBPFuZCaoLet al.Expert consensus"/>
  <result pre="Sin20144915471553 19.HijanoDRSiefkerDTShresthaBJaligamaSType I interferon potentiates IgA immunity to respiratory syncytial" exact="virus infection" post="during infancySci Rep201881103410.1038/s41598-018-29456-w30038294 20.ShenKLShangYXZhangGCXuBPFuZCaoLet al.Expert consensus on rational application"/>
  <result pre="19.HijanoDRSiefkerDTShresthaBJaligamaSType I interferon potentiates IgA immunity to respiratory syncytial virus" exact="infection" post="during infancySci Rep201881103410.1038/s41598-018-29456-w30038294 20.ShenKLShangYXZhangGCXuBPFuZCaoLet al.Expert consensus on rational application"/>
  <result pre="pediatricsChin J Appl Clin Pediatr20183313011308 21.collab: The Expert Committee on" exact="Pediatric" post="Medicine of National Healthand Commissioncollab: National Health and Family"/>
  <result pre="and Family Planningcollab: Commission of The Peopleâ€™s Republic of Chinacollab:" exact="Pediatric" post="Section of Chinese Medical Association Respiratory Groupcollab: Respiratory Disease"/>
  <result pre="Peopleâ€™s Republic of Chinacollab: Pediatric Section of Chinese Medical Association" exact="Respiratory" post="Groupcollab: Respiratory Disease Pediatric Society of Chinese Physiciansâ€™ Associationcollab:"/>
  <result pre="of Chinacollab: Pediatric Section of Chinese Medical Association Respiratory Groupcollab:" exact="Respiratory" post="Disease Pediatric Society of Chinese Physiciansâ€™ Associationcollab: Committee of"/>
  <result pre="Chinacollab: Pediatric Section of Chinese Medical Association Respiratory Groupcollab: Respiratory" exact="Disease" post="Pediatric Society of Chinese Physiciansâ€™ Associationcollab: Committee of Pediatric"/>
  <result pre="Pediatric Section of Chinese Medical Association Respiratory Groupcollab: Respiratory Disease" exact="Pediatric" post="Society of Chinese Physiciansâ€™ Associationcollab: Committee of Pediatric Chinese"/>
  <result pre="Respiratory Disease Pediatric Society of Chinese Physiciansâ€™ Associationcollab: Committee of" exact="Pediatric" post="Chinese Medicine Education AssociationGuidelines for rational drug use in"/>
  <result pre="Republic of China. Guidelines on the diagnosis and treatment of" exact="hand, foot and mouth disease" post="(2018 edition). https://www.nhc.gov.cn/yzygj/s3594q/201805/5db274d8697a41ea84e88eedd8bf8f63.shtml. Access 28 Jun 2018. 24.XuYLLiYChenYPXinSXXieLLiangYDet al.A"/>
  <result pre="on the diagnosis and treatment of hand, foot and mouth" exact="disease" post="(2018 edition). https://www.nhc.gov.cn/yzygj/s3594q/201805/5db274d8697a41ea84e88eedd8bf8f63.shtml. Access 28 Jun 2018. 24.XuYLLiYChenYPXinSXXieLLiangYDet al.A"/>
  <result pre="of recombinant human interferon Î±2b spray in the treatment of" exact="hand, foot and mouth disease" post="in childrenChin J Infect201836101106 25.collab: Infection group of pediatric"/>
  <result pre="Î±2b spray in the treatment of hand, foot and mouth" exact="disease" post="in childrenChin J Infect201836101106 25.collab: Infection group of pediatric"/>
  <result pre="hand, foot and mouth disease in childrenChin J Infect201836101106 25.collab:" exact="Infection" post="group of pediatric branch of Chinese Medical Associationcollab: National"/>
  <result pre="Chinese Medical Associationcollab: National Center for Medical Quality Control of" exact="Infectious" post="DiseasesExpert consensus on diagnosis and treatment of herpetic pharyngitis"/>
  <result pre="of Infectious DiseasesExpert consensus on diagnosis and treatment of herpetic" exact="pharyngitis" post="(2019 edition)Chin J Pediatr.201957177180 26.ShenKLShangYXZhangHA multicenter, randomized, controlled clinical"/>
  <result pre="recombinant human interferon 2b spray (pseudomonas) in the treatment of" exact="acute" post="upper respiratory tract infection in childrenChin J Appl Clin"/>
  <result pre="human interferon 2b spray (pseudomonas) in the treatment of acute" exact="upper respiratory tract infection" post="in childrenChin J Appl Clin Pediatr20193410101016 27.GaoHZhangLLWeiQDuanZJTuXMYuZAet al.Preventive and"/>
  <result pre="interferon 2b spray (pseudomonas) in the treatment of acute upper" exact="respiratory" post="tract infection in childrenChin J Appl Clin Pediatr20193410101016 27.GaoHZhangLLWeiQDuanZJTuXMYuZAet"/>
  <result pre="spray (pseudomonas) in the treatment of acute upper respiratory tract" exact="infection" post="in childrenChin J Appl Clin Pediatr20193410101016 27.GaoHZhangLLWeiQDuanZJTuXMYuZAet al.Preventive and"/>
  <result pre="therapeutic effects of recombinant IFN -Î±2b nasal spray on SARS-CoV" exact="infection" post="in Macaca mulataChin J Exp Clin Virol200519207211 28.YuDXChenQZhangLLLiuYYuZALiZFet al.A"/>
  <result pre="interferon Î±-2b for nasal spray to prevent SARS and other" exact="respiratory" post="viral infectionsChin J Exp Clin Virol200519216219 29.ChuCMRole of lopinavir/ritonavir"/>
  <result pre="Î±-2b for nasal spray to prevent SARS and other respiratory" exact="viral" post="infectionsChin J Exp Clin Virol200519216219 29.ChuCMRole of lopinavir/ritonavir in"/>
  <result pre="Organization. Home care for patients with suspected novel coronavirus (nCoV)" exact="infection" post="presenting with mild symptoms and management of contacts. https://www.who.int/internal-publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(nCoV)-infection-presenting-with-mild-symptoms-and-management-of-contacts."/>
  <result pre="contacts. https://www.who.int/internal-publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(nCoV)-infection-presenting-with-mild-symptoms-and-management-of-contacts. Access 20 Jan 2020. 34.The US Centers for" exact="Disease" post="Control and Prevention. Interim Guidance for Preventing 2019 Novel"/>
 </snippets>
</snippetsTree>
